Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Summit Healthcare Acquisition Corp.

CIK 1839185Updated Sep 29, 2026

Securities
Historical securities (4)SMIH · NASDAQ · equity · closed Mar 17, 2023LSBP · NASDAQ · equity · closed Mar 17, 2023SMIHU · NASDAQ · unit · closed Mar 16, 2023SMIHW · NASDAQ · warrant · closed Mar 16, 2023

SMIH price & chart

Provider market data
Historical security

This listing closed Mar 17, 2023. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

  1. 4 filing

    4 · 2023-03-21 · 0000899243-23-009255

  2. 4 filing

    4 · 2023-03-21 · 0000899243-23-009253

  3. 4 filing

    4 · 2023-03-21 · 0000899243-23-009251

  4. 4 filing

    4 · 2023-03-21 · 0000899243-23-009249

  5. 4 filing

    4 · 2023-03-21 · 0000899243-23-009247

Show 5 more recent filings

  1. 4 filing

    4 · 2023-03-21 · 0000899243-23-009240

  2. 15-12G filing

    15-12G · 2023-03-16 · 0001104659-23-033376

  3. 8-K filing

    8-K · 2023-03-16 · 0001104659-23-033374

  4. 25-NSE filing

    25-NSE · 2023-03-16 · 0001354457-23-000187

  5. 425 filing

    425 · 2023-03-14 · 0001104659-23-032357

Financials

FY 2021 · USD
Revenue— · FY 2021
Net income-545,727USD · FY 2021
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Operating income-549,179USD · FY 2021
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Diluted EPS— · FY 2021

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2021FY 2020
ASSETS
AssetsUSD201,034,150
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

91,374
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD885,198
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

0
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Assets, CurrentUSD1,026,875
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD20,352,001
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

70,010
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Stockholders’ equity:
Additional Paid in CapitalUSD—24,350
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Retained Earnings (Accumulated Deficit)USD-19,318,426
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

-3,636
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Stockholders' Equity Attributable to ParentUSD-19,317,851
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

21,364
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Liabilities and EquityUSD201,034,150
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

91,374
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Current liabilities:
Liabilities, CurrentUSD142,631
Source

10-K · 2022-03-31 · 0001193125-22-091035

As of 2021-12-31

70,010
Source

10-Q · 2021-08-16 · 0001193125-21-247700

As of 2020-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2021
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating ActivitiesUSD-613,225
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-200,000,000
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD201,498,423
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Additional Financial Items
General and Administrative ExpenseUSD549,179
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Investment Income, InterestUSD7,275
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD-545,727
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD3,452
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2021
Operating Income (Loss)USD-549,179
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD3,452
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD-545,727
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Additional Financial Items
General and Administrative ExpenseUSD549,179
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Investment Income, InterestUSD7,275
Source

10-K · 2022-03-31 · 0001193125-22-091035

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.